DrugBaron

OCTOBER 17, 2022

Asset-centric is a term coined by Medicxi founding partner Francesco De Rubertis to describe an investment strategy he pioneered, together with Kevin Johnson and Michele Ollier, in the early years of the 21 st Century. The key was focusing investment on a single asset to avoid the problem with pipelines in early-stage biotech companies. While it seemed superficially attractive to hedge against failure of the lead asset by having a second or a third program in the wings, the reality usually turne

Pharma Companies 100

Pharma Companies Pharmaceuticals Drug Development Production 100

Antidote

OCTOBER 17, 2022

Throughout history, clinical trials have been an important element in learning about new drugs and treatments — but without patient participation, the medical remedies that are so ubiquitous in our lives today would not exist. Because it’s required for all drugs to go through testing before they are released on the market, volunteers for clinical trials have a major impact on medical research as a whole.

Clinical Trials 98

Clinical Trials Trials Treatment Marketing 98

Eye on FDA

OCTOBER 19, 2022

Tik Tok was first released in 2016. While slow out of the starting gate with emergent media opportunities, in 2022, pharma is embracing the platform in both unbranded and branded efforts. While historically, a lot of Tik Tok use has been comprised of individuals releasing videos of them showing off dance moves and physique, the time for embracing the platform by institutional users appears has arrived.

FDA 89

FDA Regulations Research Production 89

Drug Patent Watch

OCTOBER 17, 2022

Annual Drug Patent Expirations for ARIKAYCE+KIT Arikayce Kit is a drug marketed by Insmed Inc and is included in one NDA. There are eleven patents protecting this drug. This drug…. The post New patent for Insmed Inc drug ARIKAYCE KIT appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 88

Drugs Marketing 88

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Treatment

Drug Channels

OCTOBER 18, 2022

The biosimilar boom for provider-administered drugs continues to accelerate. Net prices in therapeutic classes with biosimilar competition have declined by 60% or more over the past few years. Some major biological reference products have now lost a majority of their unit sales to their biosimilars. As we explain below, this accelerating adoption also boosts profits for pharmaceutical wholesalers and specialty distributors—particularly when these channel participants can influence which biosimi

Biosimilars 74

Biosimilars Drugs Pharmaceuticals Production 74

DS in Pharmatics

OCTOBER 20, 2022

Biologics are complex molecular entities that require extensive planning and development strategies to control development costs, ensure compliance with regulations, and speed up a product to commercialization. Hiring a biologics consultant ensures you receive expert advice and support throughout the entire CMC development process. In this article, we will outline why you should consider a biologics consulting service and what benefits this will have for your company.

Compliance 52

Compliance Regulations Production 52

Drug Patent Watch

OCTOBER 19, 2022

This chart shows the pharmaceutical companies with the most patents in Ireland. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Ireland? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 86

Pharmaceutical Companies Pharmaceuticals Drugs 86

Drug Channels

OCTOBER 21, 2022

Today’s guest post comes from Megan Marchal, Director of Specialty Pharmacy Strategy at CoverMyMeds. Megan discusses upcoming specialty medication launches. As she explains, patients will need extra help to overcome the challenges of access, affordability, and adherence. Learn more about CoverMyMeds’ patient-centric technology solutions by downloading their Access Report: Oncology Edition.

Specialty Pharmacies 72

Specialty Pharmacies Pharmacy Drugs 72

DrugBank

OCTOBER 19, 2022

Are you ready for another round-up for our latest Clinical features and updates? This season, we have new plugins, Allergies module, even better therapeutic categories and alternatives, and much more to help you bring your offerings to the next level. Let's dive in! Conditions Search Plugin and ICD-10 Search Plugin Read More Below We’ve created ready-to-use plugins that make searching conditions and ICD-10 concepts quick and easy!

Drugs 52

Drugs Treatment 52

Antidote

OCTOBER 19, 2022

The app marketplace is competitive, especially in the health and wellness sector, making user acquisition a considerable challenge. Successful app outreach requires strategic targeting and smart technology to appeal to users — and Antidote can provide these solutions. Our patient recruitment expertise translates well to assisting apps with building out their user base.

52

52

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials

Drug Patent Watch

OCTOBER 20, 2022

This chart shows the drugs with the most patents in Canada. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…. The post Which pharmaceutical drugs have the most drug patents in Canada? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceuticals 85

Pharmaceuticals Drugs 85

Advarra

OCTOBER 19, 2022

Study startup is a complicated, multi-faceted process – notoriously prone to delays due to the many stakeholders, systems, and decisions involved. One decision that can greatly impact the success and efficiency of your study is determining which sites you will partner with to conduct the study. Historically, this process has been littered with pain points and inefficiencies for both sponsors, contract research organizations (CROs), and research sites.

Clinical Trials 52

Clinical Trials Trials Research Marketing 52

DrugBank

OCTOBER 17, 2022

DrugBank’s Clinical API is a powerful tool that can be used across an array of use cases, including everything from EMR/EHR to hospice and precision medicine. We’ve intentionally built our Clinical API to connect multiple data points across unique modules as a means of delivering specific and empowering insights to the full range of our users.

Doctors 52

Doctors Production Treatment Drugs 52

Drug Channels

OCTOBER 17, 2022

Informa Connect’s Trade & Channel Strategies Summit. December 12-14, 2022 in Philadelphia, PA www.informaconnect.com/trade. Don’t miss Informa Connect's Trade & Channel Strategies Summit , coming up December 12-14, 2022 in Philadelphia! Join your colleagues from across the industry and be part of critical, solution-focused discussions designed to help optimize distribution models and channel strategies driven by market dynamics, product types, site of care and reimbursement, all delivere

Biosimilars 57

Biosimilars Pharmacy Therapies Production 57

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Clinical Trials

Drug Patent Watch

OCTOBER 21, 2022

Annual Drug Patent Expirations for DEXTENZA Dextenza is a drug marketed by Ocular Therapeutix and is included in one NDA. It is available from one supplier. There are three patents…. The post New patent for Ocular Therapeutix drug DEXTENZA appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 72

Drugs Marketing 72

Drug & Device Law

OCTOBER 18, 2022

Today’s decision comes from In re: Proton Pump Inhibitor Products Liability Litigation —an MDL pending in New Jersey. But the decision is all about the 197 Michigan plaintiffs in the MDL. The plaintiffs who either live in Michigan, got their prescription in Michigan, were diagnosed with their injury in Michigan, and/or received treatment for their injury in Michigan. 2022 WL 5265300, *1 (D.N.J.

FDA 59

FDA Compliance Production Marketing 59

Drug Patent Watch

OCTOBER 19, 2022

Annual Drug Patent Expirations for KYPROLIS Kyprolis is a drug marketed by Onyx Therap and is included in one NDA. There are eleven patents protecting this drug and three Paragraph…. The post New patent for Onyx Therap drug KYPROLIS appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs Marketing 52

Drug Patent Watch

OCTOBER 19, 2022

Annual Drug Patent Expirations for KATERZIA Katerzia is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. There are six patents protecting…. The post New patent for Azurity drug KATERZIA appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs Marketing 52

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Clinical Trials

Drug Patent Watch

OCTOBER 18, 2022

Annual Drug Patent Expirations for MAKENA+PRESERVATIVE+FREE Makena Preservative Free is a drug marketed by Covis and is included in one NDA. It is available from two suppliers. The generic ingredient…. The post New patent for COVIS drug MAKENA PRESERVATIVE FREE appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs Marketing 52

Drug Patent Watch

OCTOBER 18, 2022

Annual Drug Patent Expirations for MAKENA+%28AUTOINJECTOR%29 Makena (autoinjector) is a drug marketed by Covis and is included in one NDA. It is available from two suppliers. There are ten patents…. The post New patent for COVIS drug MAKENA (AUTOINJECTOR) appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs Marketing 52

Drug Patent Watch

OCTOBER 18, 2022

Annual Drug Patent Expirations for MAKENA Makena is a drug marketed by Covis and is included in one NDA. It is available from two suppliers. There are ten patents protecting…. The post New patent for COVIS drug MAKENA appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs Marketing 52

Drug Patent Watch

OCTOBER 17, 2022

This chart shows the pharmaceutical companies with the most patents in France. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in France? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Drugs 52

Drug Patent Watch

OCTOBER 17, 2022

Annual Drug Patent Expirations for SUMAVEL+DOSEPRO Sumavel Dosepro is a drug marketed by Endo Ventures Ltd and is included in one NDA. There are nine patents protecting this drug. SUMAVEL…. The post New patent expiration for Endo Ventures drug SUMAVEL DOSEPRO appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs Marketing 52

Drug Patent Watch

OCTOBER 17, 2022

Annual Drug Patent Expirations for MOVANTIK Movantik is a drug marketed by Redhill and is included in one NDA. It is available from three suppliers. There are six patents protecting…. The post New patent expiration for Redhill drug MOVANTIK appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs Marketing 52

Drug Patent Watch

OCTOBER 17, 2022

Annual Drug Patent Expirations for SPRAVATO Spravato is a drug marketed by Janssen Pharms and is included in one NDA. It is available from one supplier. There are five patents…. The post New patent for Janssen Pharms drug SPRAVATO appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs Marketing 52

Drug Patent Watch

OCTOBER 17, 2022

Annual Drug Patent Expirations for AUSTEDO Austedo is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from one supplier. There are eight…. The post New patent for Teva Branded drug AUSTEDO appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs Marketing 52

Drug Patent Watch

OCTOBER 17, 2022

Annual Drug Patent Expirations for GALAFOLD Galafold is a drug marketed by Amicus Therap Us and is included in one NDA. There are forty-four patents protecting this drug. This drug…. The post New patent for Amicus Therap drug GALAFOLD appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs Marketing 52

Drug Patent Watch

OCTOBER 16, 2022

This chart shows the drugs with the most patents in Croatia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…. The post Which pharmaceutical drugs have the most drug patents in Croatia? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceuticals 52

Pharmaceuticals Drugs 52

Drug Patent Watch

OCTOBER 16, 2022

Annual Drug Patent Expirations for WELCHOL Welchol is a drug marketed by Cosette and is included in four NDAs. It is available from three suppliers. There are two patents protecting…. The post New patent expiration for Cosette drug WELCHOL appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs Marketing 52

Drug Patent Watch

OCTOBER 16, 2022

Annual Drug Patent Expirations for EPRONTIA Eprontia is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. The generic ingredient in EPRONTIA…. The post New patent for Azurity drug EPRONTIA appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs Marketing 52

Drug Patent Watch

OCTOBER 15, 2022

This chart shows the pharmaceutical companies with the most lotion dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most lotion dosed drugs…. The post Which pharmaceutical companies have the most lotion dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Drugs 52

Drug Patent Watch

OCTOBER 15, 2022

Annual Drug Patent Expirations for ADDYI Addyi is a drug marketed by Sprout Pharms and is included in one NDA. It is available from one supplier. There are four patents…. The post New patent expiration for Sprout Pharms drug ADDYI appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs Marketing 52

Drug Patent Watch

OCTOBER 15, 2022

Annual Drug Patent Expirations for VENCLEXTA Venclexta is a drug marketed by Abbvie Inc and is included in one NDA. It is available from one supplier. There are eight patents…. The post New patent for Abbvie Inc drug VENCLEXTA appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs Marketing 52